Selenium Targets Resistance Biomarkers Enhancing Efficacy While Reducing Toxicity of Anti-Cancer Drugs: Preclinical and Clinical Development*
Oncotarget - United States
doi 10.18632/oncotarget.24297
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 23, 2018
Authors
Publisher
Impact Journals, LLC